Company intelligence / Profile preview

DeepMeds

Ownership: Private
Development stage: Other

Overview

DeepMeds leverages advanced deep learning technology to enhance medical imaging and assist healthcare professionals with critical decisions, particularly in traumatology and oncology. The company’s platform is designed to improve diagnostic accuracy and workflow efficiency. No clinical trial results are reported as the product is a software tool.

Therapeutic areas: OncologyOther
Modalities: Device (AI-based medical imaging software)
Industry: Medical Imaging

Beyond the preview

Go deeper on DeepMeds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeepMeds.

Explore the full profile